|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Emissions of polycyclic aromatic hydrocarbons from coking industries in China显示文摘这研究开始估计多不的芳香的烃的特征(哼) 从 coking 工业的排放,与在四典型焦炭植物进行的领域采样。为每选择植物,栈烟道气体样品在包括的进程期间是镇定的控告煤进炉(CC ) ,推焦炭(PC ) 和焦炭炉气体(CG ) 的燃烧。十六个个人在 US EPA 优先级表上哼被煤气的层析 / 团 spectrometry (GC/MS ) 分析。结果证明总数哼在烟道气体的集中从 45.776 ~ 414.874 g/m3 ,与为 CC (359.545 g/m3 ) 的最高的排放水平。集中哼在 CP1 (收费的邮票) 从 CC 过程射出从 CP3 和 CP4 (收费的顶) 是比那低的。Low-molecular-weight 哼(即,二 -- 到三戒指哼) 到总数的占优势的贡献者哼内容,和小睡, AcPy,流感, PhA,和蚂蚁被发现是最丰富的。为 CC (2.248 g/m3 ) 的全部的 BaPeq 集中比为 PC (1.838 g/m3 ) 的那些高, CG (1.082 g/m3 ) ,和 DbA 作为在从 coking 过程的排出物的 BaP 是到 carcinogenic 风险的一个重要贡献者。微粒哼比对总数的相应贡献哼的占了超过 20% 全部的 BaPeq 集中,它显著地高集体集中(5%) 。微粒并且气体哼当时,应该被考虑潜在的毒性风险哼污染在 coking 期间,过程被估计。吝啬的总数 -- 哼排放因素分别地是为 CC 和 PC 的 346.132 和 93.173 g/kg。 | Ling Mu Lin Peng Junji Cao Qiusheng He Fan Li Jianqiang Zhang Xiaofeng Liu Huiling Bai | 2013 | Particuology2013，11，1： | 17 |
| 2 | Recent advances in drug delivery applications of cubosomes,hexosomes,and solid lipid nanoparticles显示文摘The use of lipid nanocarriers for drug delivery applications is an active research area,and a great interest has particularly been shown in the past two decades.Among different lipid nanocarriers,ISAsomes(Internally self-assembled somes or particles),including cubosomes and hexosomes,and solid lipid nanoparticles(SLNs)have unique structural features,making them attractive as nanocarriers for drug delivery.In this contribution,we focus exclusively on recent advances in formation and characterization of ISAsomes,mainly cubosomes and hexosomes,and their use as versatile nanocarriers for different drug delivery applications.Additionally,the advantages of SLNs and their application in oral and pulmonary drug delivery are discussed with focus on the biological fates of these lipid nanocarriers in vivo.Despite the demonstrated advantages in in vitro and in vivo evaluations including preclinical studies,further investigations on improved understanding of the interactions of these nanoparticles with biological fuids and tissues of the target sites is necessary for effcient designing of drug nanocarriers and exploring potential clinical applications. | Anan Yaghmur Huiling Mu | 2021 | Acta Pharmaceutica Sinica B2021，11，4： | 3 |
| 3 | Value of qualitative research in polycystic ovary syndrome显示文摘 | Ma Hongxia Liang Huiling Gao Jingshu Ma Hongli Liu Jianping Ng Hungyu Ernest Billhult Annika Stener-Victorin Elisabet Mu Xin Wu Xiaoke | 2014 | Chinese Medical Journal2014，，18： | 2 |
| 4 | The metabolism of structured\striacylglycerols显示文摘 | Mu Huiling Porsgaard T | 2005 | Progress in Lipid Research2005，44，6： | 1 |
| 5 | Dia- cylglycerols from butterfat: Production by glycerol- ysis and short-path distillation and analysis of phys- ical properties显示文摘 | Yang Tiankui Zhang Hong Mu Huiling | 2004 | Journal of the American Oil Chemists'' Society2004，81，10： | 1 |
| 6 | Enzymatic interesterification of butterfat with rapeseed oil in a continuous packed bed reactor显示文摘 | Torben H Ronne Yang Tiankui Mu Huiling | 2005 | Journal of Agricultural and Food Chemistry2005，53，14： | 1 |
| 7 | Monitoring lipase-catalyzed butterfat interesterification with rapeseed oil by Fourier transform near-infrared spectroscopy显示文摘 | Hong Zhang Huiling Mu Xuebing Xu | 2006 | Analytical and Bioanalytical Chemistry2006，，6： | 1 |
| 8 | Production of structured phospholipids by lipase-catalyzed acidolysis: optimization using response surface methodology显示文摘 | Peng Lifeng Xu Xuebing Mu Huiling | 2002 | Enzyme and Microbial Technology2002，31，： | 1 |
| 9 | New human milk fat substitutes from butterfat to improve fat absorption显示文摘 | LI Yanqi MU Huiling ANDERSEN J E T | | 0，，： | 1 |
| 10 | Production of structured phospholipids by lipase-catalyzed acidolysis:optimization using response surface methodology显示文摘 | Peng Lifeng Xu Xuebing Mu Huiling | 2002 | Enzyme and Microbial Technology2002，31，： | 1 |
| 11 | Effects of different medium-chain fatty acids on intestinal absorption of structured triacylglycerols 显示文摘 | Huiling mu | 2000 | Lipids2000，35，1： | 1 |
| 12 | Bile salts and their im- portance for drug absorption显示文摘 | Rene Holm Anette Mullertz Huiling Mu | 2013 | Int J Pharm2013，453，： | 1 |
| 13 | New human milk fat substitutes from butterfat to improve fat absorption显示文摘 | Yanqi Li Huiling Mu | 2010 | Food Research International2010，43，3： | 1 |
| 14 | Diacylglycerols from butterfat:production by glycerolysis and short-path distillation and analysis of physical properties显示文摘 | YANG Tiankui ZHANG Hong MU Huiling | 2004 | J Am Oil Chem Soc2004，81，10： | 1 |
| 15 | Lipase - cata- lyzed acyl exchange of soybean phosphatidylcholine in n - hexane : a critical evaluation of both acyl incorporation and product recovery 显示文摘 | VIKBJERG A F MU Huiling XU Xuebing | 2005 | Biotechnol Progr2005，21，2： | 1 |
| 16 | Volatile com- ponents in three commercial douchies, a Chinese traditional salt-fermented soybean food 显示文摘 | Wang Lijun Mu Huiling Liu Haijie | 2010 | International Journal of Food Properties2010，，13： | 1 |
| 17 | Production of structured phospholipids by lipase-catalyzed acidolysis:optimization using response surface methodology显示文摘 | PENG Lifeng XU Xuebing MU Huiling | 2002 | Enzyme and Microbial Technology2002，31，4： | 1 |
| 18 | Volatile components in three commercial douchies,a Chinese traditional salt-fermented soybean food显示文摘 | WANG Lijun MU Huiling LIU Haijie | | 0，，： | 1 |
| 19 | Contin- uous production of structured phospholipids in a packed bed reactor with lipase from Thermornyces lanuginosa 显示文摘 | VIKBJERG A F PENG Lifeng MU Huiling | 2005 | J Am Oil Chem Soe2005，82，4： | 1 |
| 20 | Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease显示文摘Parkinson's disease(PD) is a chronic debilitating disease affecting approximately 1% of the population over the age of 60. The severity of PD is correlated to the degree of dopaminergic neuronal loss. Apomorphine has a similar chemical structure as the neurotransmitter dopamine and has been used for the treatment of advanced PD patients. In PD patients,apomorphine is normally administered subcutaneously with frequent injections because of the compound's extensive hepatic first-pass metabolism. There is, hence, a large unmet need for alternative administrative routes for apomorphine to improve patient compliance.The present review focuses on the research and development of alternative delivery of apomorphine, aiming to highlight the potential of non-invasive apomorphine therapy in PD,such as sublingual delivery and transdermal delivery. | Nrupa Borkar Huiling Mu René Holm | 2018 | Asian Journal of Pharmaceutical Sciences2018，13，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员